The Icahn Theme

This post has been updated to indicate that Spoonful of Medicine is a Nature Medicine blog.

Carl Icahn, who made a name in this field for his aggressive tactics as a Biogen Idec investor, is taking his approach to Forest Laboratories, according to this story from Bloomberg.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.